Next-Generation Spinal Interbody Devices with Advanced Porous Structures and Bioactive Surfaces

Publication ID: 24-11857430_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Spinal Interbody Devices with Advanced Porous Structures and Bioactive Surfaces,” Published Technical Disclosure No. 24-11857430_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857430_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,430.

Summary of the Inventive Concept

A novel spinal interbody device featuring advanced porous structures and bioactive surfaces that stimulate bone growth and differentiation, providing enhanced mechanical stability and personalized treatment options for patients.

Background and Problem Solved

The original patent disclosed interbody implants with optimization features, but limitations in terms of bone growth stimulation, mechanical stability, and customization led to the development of this next-generation concept. The new inventive concept addresses these limitations by incorporating bioactive surfaces, advanced porous structures, and personalized design capabilities.

Detailed Description of the Inventive Concept

The next-generation spinal interbody device comprises a bioactive surface layer that releases bioactive molecules to stimulate bone growth and differentiation. The device also features a porous structure designed to mimic the mechanical properties of cancellous bone, providing enhanced mechanical stability. Additionally, the device may incorporate a sensor system to monitor mechanical properties and bone growth over time, or a shape-memory alloy that changes shape in response to temperature changes. The device can be fabricated using a customized design process that generates a three-dimensional model of a patient's spine and optimizes the porous structure for maximum bone growth and mechanical stability.

Novelty and Inventive Step

The new claims introduce the concept of bioactive surfaces, advanced porous structures, and personalized design capabilities, which are novel and non-obvious compared to the original patent. The combination of these features provides a significant improvement in terms of bone growth stimulation, mechanical stability, and customization, making the new inventive concept a paradigm shift in the field of spinal interbody devices.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different bioactive molecules, varying porous structure designs, or alternative fabrication methods. Additionally, the device could be adapted for use in other orthopedic applications, such as joint replacements or bone grafts.

Potential Commercial Applications and Market

The next-generation spinal interbody device has significant commercial potential in the orthopedic industry, particularly in the spinal implant market. The device's advanced features and personalized design capabilities make it an attractive option for patients and surgeons seeking improved treatment outcomes. The market for spinal implants is expected to grow significantly in the coming years, driven by an increasing demand for minimally invasive procedures and personalized medicine.

CPC Classifications

SectionClassGroup
A A61 A61F2/442
A A61 A61F2/4455
A A61 A61F2/4611
A A61 A61F2/2846
A A61 A61F2002/2835
A A61 A61F2002/4629
A A61 A61F2250/0018
A A61 A61F2310/00023

Original Patent Information

Patent NumberUS 11,857,430
TitleInterbody implants and optimization features thereof
Assignee(s)Stryker European Operations Holdings LLC